• R&D
    Overview
  • Clinical

Clinical Spotlight 14
Arensia

Next Decade in Early Clinical Development:

 

The most impactful cocktail of scientific innovation and unconventional operations with focus on patients

Join Arensia for a unique day of learning, networking and a drinks reception.

Dates

06 May, 2020

Location

San Francisco Marriott Union Square Location details

Meet the Speaker

Conversation will be lead by our expert facilitators

Dr. Claudia Hesselmann, PhD

Co-founder & CEO ARENSIA EXPORATORY MEDICINE GMBH
Arensia Spotlight Session Agenda

More about ARENSIA Exploratory Medicine

ARENSIA EXPLORATORY MEDICINE is a German operator of proprietary research clinics in Eastern Europe, dedicated to performing complex Phase Ib, IIa and proof-of-concept clinical trials with novel molecules, involving patients across numerous disease areas. Given the outstanding patient recruitment rates achieved by ARENSIA clinics, we are able to dramatically reduce the overall number of sites, countries and recruitment periods for any early phase patient trial. Sponsors regard the recruiting speed and the data quality of ARENSIA as disruptive added value, providing them with a strategic advantage. As a testament to the excellent performance, ARENSIA is trusted by the world’s largest pharmaceutical and biotechnology companies, by global CROs, as well as by venture capital funds aiming to maximize their return of investment in small/virtual biotech companies. At ARENSIA, we are serving a variety of therapeutic areas, with key expertise in: oncology, immuno-inflammation, neurosciences, cardiology, respiratory, dermatology, infectious diseases, gastro-enterology, metabolics.

image_one image_two image_three

Further information?

Interested in attending this spotlight session or running your own? Drop us a message today and we will get in touch

Address
San Francisco Marriott Union Square 480 Sutter St, San Francisco, CA 94108, United States
VIEW IN GOOGLE MAPSarrow
Contact details